Back to table of contents Previous article Next article LettersFull AccessPrevalence of Psychotic Symptoms: In ReplyCarl I. Cohen, M.D., and Leslie Marino, M.D., M.P.H.Carl I. CohenSearch for more papers by this author, M.D., and Leslie MarinoSearch for more papers by this author, M.D., M.P.H.Published Online:1 Feb 2014https://doi.org/10.1176/appi.ps.650203rAboutSectionsView articleSupplemental MaterialPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail View articleIn Reply: We greatly appreciate Mr. DeVylder’s thoughtful comments. Although we had vetted our analysis with the University of Michigan staff members who manage the CPES, the two methodological points that Mr. DeVylder identified were not recognized by them or us. With respect to the underweighting of the overall sample, it was difficult to determine to what extent it would have changed the results if the sample had been properly weighted. However, the fact that the missing persons were from the NCS-R study, which had a greater number of white respondents, suggests that the overall national lifetime prevalence of psychoses might be slightly lower if the missing persons had rates of psychoses similar to rates for the NCS-R white respondents who were included.With respect to the second comment, Mr. DeVylder correctly notes that we had mistakenly assumed that persons who were missing the 12-month data should be coded as having no psychotic experiences. He presented revised data that corresponds to our reanalysis in which missing persons are excluded rather than coded as zero. The recalculated overall adjusted 12-month psychosis rate is now 2.8%, which is more consistent with rates in the literature, although it still remains on the lower end. Moreover, we reanalyzed the logistic regression analysis for the 12-month data and found that all variables that had been significantly associated with lifetime psychotic experiences in our original analysis remained significant (that is, being Latino, being black, lifetime prevalence of posttraumatic stress disorder, and higher lifetime distress). An additional variable—living in the South versus the West—was found to be significantly associated with reduced rates of psychotic experiences. We have posted a copy of the reanalysis as a data supplement to the original article.Finally, at the request of the peer reviewers of the manuscript, we included the 12-month prevalence data in our revision, although we believed that this item had a number of deficiencies. We expressed our concern about this variable in the paper, and now Mr. DeVylder has identified some other differences between the 12-month and lifetime items. Thus the reader should use appropriate caution in interpreting the 12-month findings. FiguresReferencesCited byDetailsCited byDiscrimination, psychotic experiences, and racial identity among Black Americans: Findings from the National Survey of American LifeSchizophrenia Research, Vol. 253The mental and physical health correlates of psychotic experiences among US college students: Findings from the Healthy Mind Study 202015 April 2022 | Journal of American College Health, Vol. 27COVID-19 Infection and Psychotic Experiences: Findings From the Healthy Minds Study 2020Biological Psychiatry Global Open Science, Vol. 1, No. 4Psychological Medicine, Vol. 44, No. 16 Volume 65Issue 2 February 2014Pages 270-271 Metrics PDF download History Published online 1 February 2014 Published in print 1 February 2014